SK283960B6 - Farmaceutický prostriedok na zvýšenie prietoku krvi v optickom nerve a sietnici na povrchovú úpravu - Google Patents

Farmaceutický prostriedok na zvýšenie prietoku krvi v optickom nerve a sietnici na povrchovú úpravu Download PDF

Info

Publication number
SK283960B6
SK283960B6 SK1535-97A SK153597A SK283960B6 SK 283960 B6 SK283960 B6 SK 283960B6 SK 153597 A SK153597 A SK 153597A SK 283960 B6 SK283960 B6 SK 283960B6
Authority
SK
Slovakia
Prior art keywords
blood flow
eye
optic nerve
pharmaceutical composition
retina
Prior art date
Application number
SK1535-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK153597A3 (en
Inventor
William Eric Sponsel
Alon Harris
Original Assignee
Advanced Research And Technology Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Research And Technology Institute filed Critical Advanced Research And Technology Institute
Publication of SK153597A3 publication Critical patent/SK153597A3/sk
Publication of SK283960B6 publication Critical patent/SK283960B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1535-97A 1995-05-22 1996-05-17 Farmaceutický prostriedok na zvýšenie prietoku krvi v optickom nerve a sietnici na povrchovú úpravu SK283960B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/445,839 US5789435A (en) 1995-05-22 1995-05-22 Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
PCT/US1996/007225 WO1996037203A1 (en) 1995-05-22 1996-05-17 Method to increase retinal blood flow

Publications (2)

Publication Number Publication Date
SK153597A3 SK153597A3 (en) 1998-07-08
SK283960B6 true SK283960B6 (sk) 2004-06-08

Family

ID=23770397

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1535-97A SK283960B6 (sk) 1995-05-22 1996-05-17 Farmaceutický prostriedok na zvýšenie prietoku krvi v optickom nerve a sietnici na povrchovú úpravu

Country Status (21)

Country Link
US (1) US5789435A (xx)
EP (1) EP0833632A1 (xx)
JP (1) JPH11503462A (xx)
KR (1) KR19990021853A (xx)
CN (1) CN1186019C (xx)
AU (1) AU703301B2 (xx)
BG (1) BG63148B1 (xx)
BR (1) BR9609297A (xx)
CA (1) CA2218549C (xx)
CZ (1) CZ289224B6 (xx)
EE (1) EE9700361A (xx)
HK (1) HK1020166A1 (xx)
HU (1) HUP9802553A3 (xx)
IS (1) IS4611A (xx)
NO (1) NO318600B1 (xx)
NZ (1) NZ308016A (xx)
RU (1) RU2181045C2 (xx)
SK (1) SK283960B6 (xx)
TR (1) TR199701406T1 (xx)
UA (1) UA48178C2 (xx)
WO (1) WO1996037203A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999000133A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
US6126037A (en) * 1997-09-09 2000-10-03 Merck & Co., Inc. Flow control orifice
WO1999030717A1 (en) * 1997-12-12 1999-06-24 Alcon Laboratories, Inc. Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow
CA2317121A1 (en) * 1998-01-23 1999-07-29 Merck Sharp & Dohme B.V. Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
CA2323749A1 (en) * 1998-03-06 1999-09-10 William E. Sponsel Composition and method for treating macular disorders
WO2004073708A1 (en) 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
JP4717996B2 (ja) * 2000-10-11 2011-07-06 サーパス工業株式会社 容器及びそれに用いるプラグ
US20040046934A1 (en) * 2002-02-14 2004-03-11 Board Of Regents, The University Of Texas System Oculokinetic offset acuity testing
US20040242457A1 (en) * 2003-05-27 2004-12-02 Ashby Charles R. Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
MX2007011165A (es) * 2007-09-12 2009-03-11 Arturo Jimenez Bayardo Composición farmacéutica estable de timolol, dorzolamida y brimonidina.
US10363245B2 (en) 2017-02-22 2019-07-30 The Board Of Regents Of The University Of Texas System Methods for treating CNS lesions
EP3717582B1 (en) 2017-12-03 2023-10-11 NatureWorks LLC Polylactic resin compositions for paperboard coating and paperboard coating processes using the compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416890A (en) * 1981-07-13 1983-11-22 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4426388A (en) * 1982-04-02 1984-01-17 Merck & Co., Inc. 5-Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent

Also Published As

Publication number Publication date
EE9700361A (et) 1998-06-15
NZ308016A (en) 2000-09-29
IS4611A (is) 1997-11-10
BG63148B1 (bg) 2001-05-31
NO975330D0 (no) 1997-11-20
EP0833632A4 (xx) 1998-05-20
CN1186019C (zh) 2005-01-26
CA2218549C (en) 2005-09-20
HUP9802553A3 (en) 2002-01-28
AU703301B2 (en) 1999-03-25
UA48178C2 (uk) 2002-08-15
RU2181045C2 (ru) 2002-04-10
CZ369497A3 (cs) 1998-06-17
AU5754096A (en) 1996-12-11
MX9709063A (es) 1998-10-31
BG102064A (en) 1998-07-31
JPH11503462A (ja) 1999-03-26
CN1199336A (zh) 1998-11-18
US5789435A (en) 1998-08-04
KR19990021853A (ko) 1999-03-25
CZ289224B6 (cs) 2001-12-12
NO975330L (no) 1998-01-07
WO1996037203A1 (en) 1996-11-28
TR199701406T1 (xx) 1998-03-21
BR9609297A (pt) 1999-08-17
SK153597A3 (en) 1998-07-08
EP0833632A1 (en) 1998-04-08
HUP9802553A2 (hu) 1999-04-28
CA2218549A1 (en) 1996-11-28
NO318600B1 (no) 2005-04-18
HK1020166A1 (en) 2000-03-31

Similar Documents

Publication Publication Date Title
US4386098A (en) 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
KR100884711B1 (ko) 외용 투여용 올로파타딘 제제
SK283960B6 (sk) Farmaceutický prostriedok na zvýšenie prietoku krvi v optickom nerve a sietnici na povrchovú úpravu
US4045558A (en) Pilocarpine salts
SK284371B6 (sk) Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva
EP0509752B1 (en) Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
US4542152A (en) 5-[Phenylsulfonyl(or sulfinyl)]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US6316443B1 (en) Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
EP0140789B1 (en) Use of peripherally selective dopamine antagonists for the preparation of a medicament for the topical treatment of ocular hypertension
EP0014642B1 (en) Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitors and s-(-)-1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yl)-oxy-2-propanol for topical application in the treatment of elevated intraocular pressure
US4585787A (en) 5-[2(Or 3)-hydroxyphenylsulfonyl]thiophene-2-sulfonamides for the topical treatment of elevated intraocular pressure
US4454148A (en) 5-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4510155A (en) 6(or 5)-Hydroxybenzothiazole-2-sulfonamide-O-sulfate salts for the topical treatment of elevated intraocular pressure
EP0034542B1 (en) S-(-)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)-oxy)-2-propanol pamoate for topical application in the treatment of elevated intraocular pressure
LV10388B (en) Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a -adrenergic antagonist
CN1155243A (zh) 眼部炎症和/或伤口的预防和治疗方法

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110517